Astrocytes and gliotransmitters: new players in the treatment of major depression?

Abstract

With a lifetime prevalence of more than 16% worldwide, major depressive disorder is one of the most common psychiatric disorders. Only one third of patients experience a complete therapeutic improvement with the use of current antidepressant drugs, with a therapeutic effect appearing only after several weeks of treatment. Hence, a better understanding of… (More)

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.